Dyne Therapeutics Market Sentiment

Dyne Therapeutics Inc

DYNNASDAQ

Trade with Public

$19.07

-5.21-21.44%

Last update: Sep 8, 10:44 AM

PRO

Why Is It Moving?™:Dyne Therapeutics shares are trading lower. The company announced it will p...

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Dyne Therapeutics Market Sentiment

Market sentiment signals for Dyne Therapeutics (DYN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Outperform

Short Interest▲ 14.7% short float

Options Flow▲ 0.60 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Outperform

23 analysts

Options Flow (P/C)

0.60

More calls — Bullish

357 calls · 215 puts

Avg Consensus PT

$40

+110.4%

Highest Price Target

$56

+193.6%

Raymond James

Lowest Price Target

$16

-16.1%

JP Morgan

Short Interest

14.7%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Jul 31, 2026	Morgan Stanley	Michael Ulz—	+135.9%	$47 → $45	Maintained	Overweight
Jul 30, 2026	RBC Capital	Luca Issi—	+83.5%	$30 → $35	Maintained	Outperform
Jul 23, 2026	Cantor Fitzgerald	Eric Schmidt—	—	—	Initiate	Overweight
Jun 26, 2026	TD Cowen	Joseph Thome—	—	—	Initiate	Buy
May 15, 2026	Evercore ISI Group	Gavin Clark-Gartner—	+73.0%	$34 → $33	Maintained	Outperform
May 13, 2026	Bernstein	William Pickering—	+25.8%	$23 → $24	Maintained	Market Perform
Mar 9, 2026	Chardan Capital	Keay Nakae—	+99.2%	$38 → $38	Maintained	Buy
Mar 3, 2026	Morgan Stanley	Michael Ulz—	+146.4%	$50 → $47	Maintained	Overweight
Mar 3, 2026	Chardan Capital	Keay Nakae—	+99.2%	$38 → $38	Maintained	Buy
Mar 3, 2026	HC Wainwright & Co.	Ananda Ghosh—	+162.1%	$60 → $50	Maintained	Buy
Jan 20, 2026	JP Morgan	Tessa Romero—	-16.1%	$17 → $16	Maintained	Neutral
Dec 15, 2025	Evercore ISI Group	Gavin Clark-Gartner—	+88.7%	$38 → $36	Maintained	Outperform
Dec 11, 2025	Stifel	Paul Matteis—	+104.5%	$36 → $39	Maintained	Buy
Dec 10, 2025	Oppenheimer	Andreas Argyrides—	+109.7%	$11 → $40	Upgrade	Perform→Outperform
Dec 9, 2025	Morgan Stanley	Michael Ulz—	+162.1%	$46 → $50	Maintained	Overweight
Dec 9, 2025	Chardan Capital	Keay Nakae—	+99.2%	$38 → $38	Maintained	Buy
Dec 8, 2025	HC Wainwright & Co.	Ananda Ghosh—	+214.5%	$46 → $60	Maintained	Buy
Nov 14, 2025	JP Morgan	Tessa Romero—	-10.9%	$18 → $17	Maintained	Neutral
Nov 12, 2025	Oppenheimer	Andreas Argyrides—	-42.3%	$13 → $11	Maintained	Perform
Nov 6, 2025	HC Wainwright & Co.	Ananda Ghosh—	+141.2%	$38 → $46	Maintained	Buy
Nov 6, 2025	RBC Capital	Luca Issi—	+57.3%	$23 → $30	Maintained	Outperform
Oct 10, 2025	Oppenheimer	Andreas Argyrides—	-31.8%	$13 → $13	Downgrade	Outperform→Perform
Aug 25, 2025	Raymond James	Martin Auster—	+83.5%	$31 → $35	Upgrade	Outperform→Strong Buy
Aug 6, 2025	Oppenheimer	Andreas Argyrides—	-31.8%	$34 → $13	Maintained	Outperform
Jul 31, 2025	Stifel	Paul Matteis—	+88.7%	$66 → $36	Maintained	Buy